Subbu Nambi Stock Analyst Profile - Guggenheim Research Coverage - Stocknear

Subbu Nambi

Stock Analyst at Guggenheim

(3.81)
# 2177
Out of 5,459 analysts
44
Total ratings
Success rate
Average return
22 Stocks
Name Action PT Current % Upside Ratings Updated
CAI Caris Life Sciences
Maintains: Strong Buy
32 36
38.22 -5.81% 2 Aug 13, 2025
DHR Danaher
Reiterates: Buy
250 250
205.01 21.95% 2 Jul 23, 2025
WGS GeneDx Holdings
Maintains: Strong Buy
88 115
129.19 -10.98% 1 Jun 30, 2025
TEM Tempus AI
Maintains: Strong Buy
65 75
73.21 2.45% 3 Jun 30, 2025
NEOG Neogen
Maintains: Buy
13 10
5.74 74.22% 3 Jun 30, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
122 114
99.54 14.53% 3 May 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
50 50
27.19 83.89% 2 May 6, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
10 10
8.77 14.03% 1 Apr 16, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
60 60
46.71 28.45% 2 Apr 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
45 37
28.61 29.33% 3 Apr 9, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
n/a
n/a n/a 3 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
56 56
63.5 -11.81% 5 Feb 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
170 200
163.04 22.67% 2 Jan 17, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Oct 17, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
3.35 79.1% 1 Jun 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
6
0.7 757.14% 1 Jun 27, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Jun 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Jun 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
22.28 12.21% 1 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Dec 14, 2023